OXFORD, UK--Incyte Pharmaceuticals and Oxford GlycoSciences announced the second of three new programs the companies have developed to integrate gene and protein expression data. PharmacoProgram applies proteomics technology to study compound efficacy and safety. Customers will be able to purchase multiyear access to PharmacoProgram along with a predetermined number of customer-driven gene and expression analysis experiments.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.